Foghorn Therapeutics Inc (FHTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 9,247 | 8,153 | 7,557 | 5,952 | 2,856 |
| Gross Profit | 9,247 | 8,153 | 7,557 | 5,952 | 2,856 |
| Operating Expenses | 33,125 | 26,654 | 28,654 | 28,865 | 26,861 |
| Operating Income | -23,878 | -18,501 | -21,097 | -22,913 | -24,005 |
| Other Income | 2,214 | 2,652 | 3,161 | 4,079 | 4,502 |
| Pre-tax Income | -21,664 | -15,849 | -17,936 | -18,834 | -19,503 |
| Net Income Continuous | -21,664 | -15,849 | -17,936 | -18,834 | -19,503 |
| Net Income | $-21,664 | $-15,849 | $-17,936 | $-18,834 | $-19,503 |
| EPS Basic Total Ops | -0.35 | -0.25 | -0.28 | -0.30 | -0.23 |
| EPS Basic Continuous Ops | -0.34 | -0.25 | -0.28 | -0.30 | -0.24 |
| EPS Diluted Total Ops | -0.35 | -0.25 | -0.28 | -0.30 | -0.23 |
| EPS Diluted Continuous Ops | -0.34 | -0.25 | -0.28 | -0.30 | -0.24 |
| EPS Diluted Before Non-Recurring Items | -0.34 | -0.25 | -0.28 | -0.30 | -0.30 |
| EBITDA(a) | $-23,382 | $-18,005 | $-20,692 | $-22,904 | $-24,813 |